Public Company News

EZGO Announces $8.5 Million Registered Direct Offering

CHANGZHOU, China, June 6, 2023 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or the "Company"), a leading short-distance transportation solutions provider inChina, today announced that it has entered into a definitive securities purchase agreement, dated as ofJune 5, 2023 (the "P...

2023-06-06 18:00 4000

New Oriental Extends Share Repurchase Program

BEIJING, June 6, 2023 /PRNewswire/ -- New Oriental Education & Technology Group Inc. ("New Oriental" or the "Company") (NYSE: EDU and SEHK: 9901), a provider of private educational services inChina, today announced that its board of directors has authorized the Company to extend its share repurch...

2023-06-06 17:00 2780

36Kr Holdings Inc. Reports First Quarter 2023 Unaudited Financial Results

BEIJING, June 6, 2023 /PRNewswire/ -- 36Kr Holdings Inc. ("36Kr" or the "Company" or "We") (NASDAQ: KRKR), a prominent brand and a pioneering platform dedicated to serving New Economy participants inChina, today announced its unaudited financial results for the first quarter endedMarch 31, 2023. ...

2023-06-06 17:00 4047

Hello Group Inc. Announces Unaudited Financial Results for the First Quarter of 2023

BEIJING, June 6, 2023 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) ("Hello Group" or the "Company"), a leading mobile social and entertainment platform in China, today announced its unaudited financial results for the first quarter of 2023.    First Quarter of 2023 Highlights * Net revenues...

2023-06-06 15:30 4068

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

SUZHOU, China and ROCKVILLE, Md., June 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that for the second consecutive year, it has release...

2023-06-06 12:20 4178

USANA Malaysia Named Top Combination Dietary Supplements Brand by Euromonitor International

USANA Malaysia awarded for fifth year in a row KUALA LUMPUR, Malaysia, June 6, 2023 /PRNewswire/ -- USANA Malaysia was recently awarded the title Top #1 Combination Dietary Supplements Brand in Malaysia by market research giant Euromonitor International—earning this elite recognition for the fift...

2023-06-06 11:00 6537

Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential

SUZHOU, China and ROCKVILLE, Md,, June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released preliminary results from a Phas...

2023-06-06 10:45 2978

AGBA Group (NASDAQ: 'AGBA') Comments on its Share Price Performance Since Listing in November 2022

HONG KONG, June 5, 2023 /PRNewswire/ -- NASDAQ-listed, AGBA Group Holding Limited ("AGBA"), the leading one-stop financial supermarket inHong Kong, today provided context for its share price performance since the de-SPAC transaction inNovember 2022, which has fallen short of AGBA's expectations. ...

2023-06-05 21:10 4102

E-Home Household Services Holdings Limited Jiangxi Branch Established and Headquarters Signed New Contracts of Over RMB 10 Million in April to May

FUZHOU, China, June 5, 2023 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:  EJH) (the "Company" or "eHome"), an integrated home services provider in China,  the Company today announced E-Home Household Services Holdings Limited Service provider: YiJiaQin (Fujian) Jiangxi Bran...

2023-06-05 21:00 3506

Fresh2 Group Ltd. Announces US$4.4 Million Private Placement

NEW YORK, June 5, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES), a company with operations in the United States and China focused on early cancer screening and detection and plans to enter into the operation of  a business-to-business e-commer...

2023-06-05 21:00 3851

High Growth and High Profit, Chindata Group Announced 2023 Q1 Financial Report

BEIJING, June 5, 2023 /PRNewswire/ -- Chindata Group, ("Chindata" or the "Company") (Nasdaq: CD), an industry leader in carrier-neutral hyperscale data center solutions, released its unaudited financial report for the first quarter endedMarch 31, 2023. To supplement the Company's consolidated fin...

2023-06-05 21:00 3891

GigaMedia Announces Amendment to One Exhibit in Notice of Annual General Meeting of Shareholders and Proxy Statement Previously Announced on May 19, 2023

TAIPEI, June 5, 2023 /PRNewswire/ -- GigaMedia Limited (NASDAQ: GIGM) previously released an announcement datedMay 19, 2023 for Notice of Annual General Meeting of Shareholders and Proxy Statement.  The Company made an amendment today to clarify Exhibit 99.3 to the Notice, and attached the corre...

2023-06-05 21:00 4092

WiMi Hologram Cloud Launches Its Transformer Algorithm-based WiMi AI Assistant

BEIJING, June 5, 2023 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today launched an artificial intelligence assistant using an advanced transformer algorithm, called WiMi AI Assistant, w...

2023-06-05 20:00 3030

Cango Inc. to Report First Quarter 2023 Financial Results on June 8, 2023 Eastern Time

SHANGHAI, June 5, 2023 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a leading automotive transaction service platform inChina, today announced that it plans to release its first quarter 2023 financial results after the market closes onThursday, June 8, 2023. The earnings re...

2023-06-05 20:00 2717

Baidu's 2022 ESG Report Highlights "Safe and Controllable" as Highest Principle of AI Ethics

BEIJING, June 5, 2023 /PRNewswire/ -- Baidu, Inc. (NASDAQ: BIDU and HKEX: 9888) ("Baidu" or the "Company") has recently released its 2022 ESG report, providing updates to the company's 2022 ESG performance in critical areas including enhancing corporate governance, building trust, nurturing talen...

2023-06-05 18:50 3071

Live from ASCO 2023 | For the Third Consecutive Year, Ascentage Pharma Releases Promising Results of Alrizomadlin plus Pembrolizumab in Patients with Cutaneous Melanoma that Failed Immuno-Oncologic (IO) Therapies

SUZHOU, China, and ROCKVILLE, Md., June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated results from a Phase I...

2023-06-05 17:34 3022

Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage with AI-Powered Mammography Analysis

- Lunit and Sweden's largest private hospital pioneering a new approach to combine radiologists' expertise with AI SEOUL, South Korea, June 5, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, today announced the signing of a supply ...

2023-06-05 15:00 2950

Gencurix Announces Clinical Research Results At ASCO 2023 Demonstrating Outstanding Performance of GenesWell BCT, the Company's Breast Cancer Prognostic Test, Compared to Global Best-Selling Test, OncotypeDX

SEOUL, South Korea, June 4, 2023 /PRNewswire/ -- Gencurix (KOSDAQ #229000), a leading provider of cancer molecular diagnostics, announced the release of clinical research results directly comparing the accuracy of its breast cancer prognostic test, GenesW...

2023-06-05 14:37 3690

American Society of Clinical Oncology confers highest honor upon Prof Hagop Kantarjian

SUZHOU, China and ROCKVILLE, Md., June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that its Clinical Advisory Board member ProfHago...

2023-06-05 12:30 2595

Live from ASCO 2023 | Updated Data of Olverembatinib in SDH-Deficient GIST including a CBR of 93.8% Signals a Potential Clinical Breakthrough

SUZHOU, China and ROCKVILLE, Md., June 4, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated clinical results of olv...

2023-06-05 11:51 2869
1 ... 456457458459460461462 ... 759